Phase 2 Trial of Concurrent Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-Induced Peripheral Neuropathy in Patients of Multiple Myeloma
第一作者机构：[1]Sun Yat Sen Univ, Ctr Canc, Dept Hematol Oncol, Guangzhou 510275, Guangdong, Peoples R China
推荐引用方式(GB/T 7714)：
Wang Liang,Xia Zhongjun,Chen Xiaoqin.Phase 2 Trial of Concurrent Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-Induced Peripheral Neuropathy in Patients of Multiple Myeloma[J].BLOOD.2015,126(23):
APA：
Wang, Liang,Xia, Zhongjun&Chen, Xiaoqin.(2015).Phase 2 Trial of Concurrent Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-Induced Peripheral Neuropathy in Patients of Multiple Myeloma.BLOOD,126,(23)
MLA：
Wang, Liang,et al."Phase 2 Trial of Concurrent Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-Induced Peripheral Neuropathy in Patients of Multiple Myeloma".BLOOD 126..23(2015)
医学